ASX:NXT.AX 9 February 2026

March 22, 2026, 11:28 PM EDT. Aflac's stock price has fallen 6.8% over the past month, now trading around $106. Despite this pullback, the insurance company's share price remained flat over the last year. Analysts highlight a historical 80.4% return over three years and 131% over five years. Valuation checks rate Aflac 2 out of 6, but an Excess Returns analysis suggests the stock could be undervalued by about 40.9%, with an intrinsic value estimated at $179.78 per share. The return on equity of 14.09% exceeds its cost of equity, supporting potential upside. The current price-to-earnings ratio stands at 15.01, reflecting market views on growth and risk. Investors might consider reassessing Aflac as a buying opportunity amid recent price weakness.